Literature DB >> 19839254

The use of fibrin sealant as a glue for septoplasty and conchotomy.

Michael Vaiman1, Shlomo Sarfaty, Ephraim Eviatar.   

Abstract

OBJECTIVE: The aim of our study was to investigate glue properties of a fibrin sealant in cases of septoplasty and conchotomy.
DESIGN: Double-blind prospective randomized study.
MATERIALS AND METHODS: A study of 146 patients (80 M, 66 F) who underwent septoplasty and conchotomy was performed in Assaf Harofeh Medical Center Tzrifin, Israel. The patients were divided randomly into two groups: Group I (n = 74) underwent septoplasty with transseptal suturing, and conchotomy with glue as a haemostatic. Group II (n = 72) underwent septoplasty and conchotomy with glue as a haemostatic as well as septal cartilage and mucoperichodrial flaps sealant (no transseptal suturing). The glue was based on a concentrate of human clottable proteins and purified native human thrombin.
RESULTS: Our results showed complete healing in both groups without significant differences. One late postoperative nasal bleeding occurred in group I, and none in group II.
CONCLUSION: We conclude that the use of second-generation glue in endonasal surgery is well suited to stop nasal bleeding and seal intranasal flaps. Moreover, it might help to avoid transseptal suturing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839254     DOI: 10.4193/Rhin08.156

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  3 in total

Review 1.  Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

2.  Human Fibrin Sealant: Effective Hemostasis in Otolaryngologic Surgeries.

Authors:  Sanjiv Badhwar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-09

3.  Septal stapler use during septum surgery.

Authors:  Güven Yildirim; Cemal Cingi; Ercan Kaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-28       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.